Bellevue Group AG - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2018$1,459,000
+16.8%
75,0000.0%0.14%
+11.5%
Q4 2017$1,249,000
-29.3%
75,000
-13.8%
0.13%
-29.7%
Q3 2017$1,766,000
-37.3%
87,000
-50.3%
0.18%
-44.4%
Q2 2017$2,818,000
+25.1%
175,000
+84.2%
0.33%
-18.2%
Q3 2016$2,252,000
-17.8%
95,0000.0%0.41%
-21.0%
Q2 2016$2,738,000
-20.8%
95,000
-12.0%
0.52%
-18.0%
Q1 2016$3,458,000108,0000.63%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders